Walleye Trading’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.6M Sell
830,500
-47,100
-5% -$3.63M 0.1% 208
2025
Q4
$69.6M Sell
877,600
-194,900
-18% -$15.4M 0.1% 208
2025
Q3
$80.9M Buy
1,072,500
+128,000
+14% +$8.77M 0.12% 157
2025
Q2
$65.2M Buy
944,500
+304,300
+48% +$20M 0.12% 159
2025
Q1
$43.4M Sell
640,200
-94,100
-13% -$5.63M 0.1% 202
2024
Q4
$33M Buy
734,300
+77,100
+12% +$4.33M 0.07% 309
2024
Q3
$41.3M Sell
657,200
-32,100
-5% -$1.87M 0.09% 242
2024
Q2
$40.7M Buy
689,300
+197,900
+40% +$12.4M 0.1% 207
2024
Q1
$39.2M Sell
491,400
-149,200
-23% -$11.4M 0.08% 222
2023
Q4
$50.6M Sell
640,600
-292,800
-31% -$20.8M 0.11% 161
2023
Q3
$65.2M Buy
933,400
+542,500
+139% +$38.4M 0.17% 83
2023
Q2
$27M Buy
390,900
+76,000
+24% +$5.41M 0.08% 214
2023
Q1
$23.4M Buy
314,900
+145,400
+86% +$12.2M 0.05% 330
2022
Q4
$15.8M Sell
169,500
-133,300
-44% -$12.9M 0.05% 459
2022
Q3
$28.9M Buy
302,800
+64,900
+27% +$6.42M 0.09% 218
2022
Q2
$22M Buy
237,900
+84,400
+55% +$8.24M 0.07% 288
2022
Q1
$15.5M Sell
153,500
-60,900
-28% -$6.4M 0.05% 447
2021
Q4
$22.1M Buy
214,400
+20,900
+11% +$1.93M 0.07% 284
2021
Q3
$16.4M Sell
193,500
-1,600
-0.8% -$134K 0.06% 344
2021
Q2
$16.3M Sell
195,100
-19,500
-9% -$1.6M 0.06% 282
2021
Q1
$16.1M Buy
214,600
+27,600
+15% +$2.01M 0.07% 194
2020
Q4
$12.8M Sell
187,000
-48,400
-21% -$3.15M 0.06% 310
2020
Q3
$13.7M Buy
235,400
+87,700
+59% +$5.46M 0.07% 195
2020
Q2
$9.6M Sell
147,700
-106,600
-42% -$6.71M 0.06% 289
2020
Q1
$15.1M Buy
254,300
+17,794
+8% +$1.19M 0.12% 105
2019
Q4
$17.6M Buy
236,506
+74,100
+46% +$5.2M 0.12% 148
2019
Q3
$10.2M Buy
162,406
+8,100
+5% +$480K 0.09% 191
2019
Q2
$8.41M Sell
154,306
-311,366
-67% -$16.8M 0.07% 250
2019
Q1
$25.1M Buy
465,672
+6,674
+1% +$412K 0.2% 58
2018
Q4
$30.1M Buy
458,998
+233,298
+103% +$17.4M 0.22% 59
2018
Q3
$17.8M Sell
225,700
-31,400
-12% -$2.24M 0.09% 173
2018
Q2
$16.5M Sell
257,100
-153,900
-37% -$10.1M 0.09% 170
2018
Q1
$25.6M Buy
411,000
+277,600
+208% +$19.9M 0.15% 77
2017
Q4
$9.67K Buy
133,400
+63,800
+92% +$4.64M 0.05% 355
2017
Q3
$5.66K Buy
69,600
+9,200
+15% +$728K 0.03% 586
2017
Q2
$4.86K Sell
60,400
-255,400
-81% -$20.2M 0.03% 598
2017
Q1
$24.8K Buy
315,800
+268,700
+570% +$21.5M 0.17% 63
2016
Q4
$3.72M Buy
47,100
+25,600
+119% +$2.07M 0.03% 571
2016
Q3
$1.91M Sell
21,500
-52,700
-71% -$4.97M 0.01% 1002
2016
Q2
$7.11M Sell
74,200
-44,300
-37% -$4.41M 0.05% 298
2016
Q1
$12.3M Buy
118,500
+82,500
+229% +$8.02M 0.11% 160
2015
Q4
$3.52M Sell
36,000
-10,800
-23% -$1.06M 0.03% 492
2015
Q3
$4.51M Hold
46,800
0.04% 342
2015
Q2
$4.91M Buy
46,800
+3,500
+8% +$358K 0.05% 333
2015
Q1
$4.47M Buy
43,300
+35,400
+448% +$3.58M 0.04% 350
2014
Q4
$761K Buy
7,900
+3,600
+84% +$317K 0.01% 1236
2014
Q3
$343K Sell
4,300
-10,200
-70% -$804K ﹤0.01% 1635
2014
Q2
$1.09K Sell
14,500
-10,200
-41% -$771K 0.01% 754
2014
Q1
$1.85K Buy
24,700
+3,600
+17% +$254K 0.03% 505
2013
Q4
$1.51M Buy
21,100
+13,700
+185% +$880K 0.01% 823
2013
Q3
$421K Sell
7,400
-20,500
-73% -$1.22M ﹤0.01% 1314
2013
Q2
$1.59M Buy
+27,900
New +$1.62M 0.02% 680

Other funds holding CVS

Walleye Trading's CVS Position: Q1 2026 in Review

Walleye Trading increased its CVS Health (CVS) stake by 45% in Q1 2026, buying an estimated $10.3M and bringing the position to 427,542 shares worth $30.7M. The position accounts for 0.05% of the portfolio, ranked #361.

Walleye Trading first reported a position in CVS in Q3 2013 and has held it in 39 quarters since. The position peaked at $37.3M in Q4 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Walleye Trading held 427,542 shares of CVS Health worth $30.7M as of Q1 2026.
  • Walleye Trading bought 133,578 CVS Health shares in Q1 2026, an estimated $10.3M.
  • CVS Health made up 0.05% of Walleye Trading's portfolio in Q1 2026, its #361 holding.
  • Walleye Trading first reported a position in CVS Health in Q3 2013 and has held it in 39 quarters since.
  • Walleye Trading's CVS Health position peaked at $37.3M in Q4 2023.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.